68 related articles for article (PubMed ID: 30632843)
1. The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.
Lasica M; Willcox A; Burbury K; Ross DM; Branford S; Butler J; Filshie R; Januszewicz H; Joske D; Mills A; Simpson D; Tam C; Taylor K; Watson AM; Wolf M; Grigg A
Leuk Lymphoma; 2019 Jul; 60(7):1796-1802. PubMed ID: 30632843
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies.
Bhattacharjee U; Jandial A; Singh C; Lekshmon KS; Mishra K; Sandal R; Nampoothiri R; Naseem S; Suri V; Jain A; Lad DP; Prakash G; Khadwal A; Malhotra P
Leuk Res; 2023 Oct; 133():107367. PubMed ID: 37566974
[TBL] [Abstract][Full Text] [Related]
3. SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra".
Abruzzese E; Trawinska MM; De Fabritiis P; Bernardi S
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):214-223. PubMed ID: 38151389
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Abou Dalle I; Jabbour E; Short NJ; Ravandi F
Curr Treat Options Oncol; 2019 Jan; 20(1):4. PubMed ID: 30675645
[TBL] [Abstract][Full Text] [Related]
5. Risks and challenges of CML management during pregnancy: Looking for a balanced decision.
Chelysheva E; Turkina A
Eur J Haematol; 2019 Apr; 102(4):378-379. PubMed ID: 30672625
[No Abstract] [Full Text] [Related]
6. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
Assunção PM; Lana TP; Delamain MT; Duarte GO; Zulli R; Lorand-Metze I; de Souza CA; de Paula EV; Barbosa Pagnano KB
Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):162-166. PubMed ID: 30660512
[TBL] [Abstract][Full Text] [Related]
7. Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib.
Ramsey LB; Mizuno T; Vinks AA; O'Brien MM
Pediatr Blood Cancer; 2019 May; 66(5):e27618. PubMed ID: 30677213
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A
Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211
[No Abstract] [Full Text] [Related]
9. Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.
Sakurai M; Kikuchi T; Karigane D; Kasahara H; Matsuki E; Hashida R; Yamane Y; Abe R; Koda Y; Toyama T; Kato J; Shimizu T; Yokoyama Y; Suzuki S; Nakamura T; Okamoto S; Mori T
Int J Hematol; 2019 Mar; 109(3):292-298. PubMed ID: 30680668
[TBL] [Abstract][Full Text] [Related]
10. Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.
Dou X; Qin Y; Huang X; Jiang Q
Oncologist; 2019 Nov; 24(11):e1141-e1147. PubMed ID: 31186377
[TBL] [Abstract][Full Text] [Related]
11. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.
Hochhaus A; Baccarani M; Silver RT; Schiffer C; Apperley JF; Cervantes F; Clark RE; Cortes JE; Deininger MW; Guilhot F; Hjorth-Hansen H; Hughes TP; Janssen JJWM; Kantarjian HM; Kim DW; Larson RA; Lipton JH; Mahon FX; Mayer J; Nicolini F; Niederwieser D; Pane F; Radich JP; Rea D; Richter J; Rosti G; Rousselot P; Saglio G; Saußele S; Soverini S; Steegmann JL; Turkina A; Zaritskey A; Hehlmann R
Leukemia; 2020 Apr; 34(4):966-984. PubMed ID: 32127639
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.
Madabhavi I; Sarkar M; Modi M; Kadakol N
J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience.
Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE
Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580
[TBL] [Abstract][Full Text] [Related]
14. Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML).
Loh JBE; Walker P; Avery S; Patil S; Spencer A; Wei A; Fleming S
Leuk Lymphoma; 2021 Feb; 62(2):489-491. PubMed ID: 33047641
[No Abstract] [Full Text] [Related]
15. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
Bhurani M; Admojo L; Van Der Weyden C; Twigger R; Bazargan A; Quach H; Zimet A; Coyle L; Lindsay J; Radeski D; Hawkes E; Kennedy G; Irving I; Gutta N; Trotman J; Yeung J; Dunlop L; Hua M; Giri P; Yuen S; Panicker S; Moreton S; Khoo L; Scott A; Kipp D; McQuillan A; McCormack C; Dickinson M; Prince HM
Leuk Lymphoma; 2021 Feb; 62(2):330-336. PubMed ID: 33026266
[TBL] [Abstract][Full Text] [Related]
16. Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1868-1875. PubMed ID: 32640314
[TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon and pregnancy in a patient with CML.
Lipton JH; Derzko CM; Curtis J
Hematol Oncol; 1996 Sep; 14(3):119-22. PubMed ID: 9119356
[TBL] [Abstract][Full Text] [Related]
18. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Kim YH; Prince HM; Whittaker S; Horwitz SM; Duvic M; Bechter O; Sanches JA; Stadler R; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown LC; Ortiz-Romero PL; Akilov OE; Trotman J; Taylor K; Weichenthal M; Walewski J; Fisher D; McNeeley M; Gru AA; Brown L; Palanca-Wessels MC; Lisano J; Onsum M; Bunn V; Little M; Trepicchio WL; Dummer R
Eur J Cancer; 2021 May; 148():411-421. PubMed ID: 33794441
[TBL] [Abstract][Full Text] [Related]
19. Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma.
Tam CS; Quach H; Nicol A; Badoux X; Rose H; Prince HM; Leahy MF; Eek R; Wickham N; Patil SS; Huang J; Prathikanti R; Cohen A; Elstrom R; Reed W; Schneider J; Flinn IW
Blood Adv; 2020 Oct; 4(19):4802-4811. PubMed ID: 33022066
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Disease Is Associated With Human T-Cell Leukemia Virus Type 1c Infection: A Cross-sectional Survey in Remote Aboriginal Communities.
Einsiedel L; Pham H; Talukder MRR; Liddle J; Taylor K; Wilson K; Jersmann H; Gessain A; Woodman R; Kaldor J
Clin Infect Dis; 2021 Oct; 73(7):e1498-e1506. PubMed ID: 32936911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
